MedTrace Logo

Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD)

NCT02535884 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2022-01-21

No results posted yet for this study

Summary

The aim of the study is to prove the efficacy and safety of pallidal DBS in HD patients and to show superiority of DBS on motor function in the stimulation group compared to stimulation-off group

Conditions

  • Huntington Disease

Interventions

DEVICE

ACTIVA® PC neurostimulator (Model 37601)

the stimulator in the stimulation group will be turned on after implantation of the device

Sponsors & Collaborators

  • KKS Netzwerk

    collaborator NETWORK

  • Medtronic

    collaborator INDUSTRY

  • The George Institute

    collaborator OTHER

  • Egyptian Society of Neurological Surgeons

    collaborator OTHER

  • CHDI Foundation, Inc.

    collaborator OTHER

  • Heinrich-Heine University, Duesseldorf

    lead OTHER

Principal Investigators

  • Jan Vesper, Prof Dr. · Dept. of Functional Neurosurgery and Stereotaxy

  • Alfons Schnitzler, Prof Dr · Dept.of Neurology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Austria
  • France
  • Germany
  • Switzerland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02535884 on ClinicalTrials.gov